REM-0046127
- Generic Name
- REM-0046127
A Phase 1 (First in Human) Randomized, Double-blind, Placebo-controlled SAD, MAD Study With Oral REM0046127
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- reMYND
- Target Recruit Count
- 77
- Registration Number
- NCT04672135
- Locations
- 🇦🇹
Medical University Vienna, Department of Clinical Pharmacology, Vienna, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath